Disseminated Herpes Zoster with Decreased CD4 Counts in a HIV-Infected Patient

References

• Kennedy PGE, Gershon AA. Clinical features of varicella-zoster virus infection. Viruses. 2018;10(11):609. doi:10.3390/v10110609
   PubMed Web of Science ®Google Scholar
• Ellis DL, Barsell A, Riahi RR, et al. Varicella zoster virus encephalitis in a patient with disseminated herpes zoster: report and review of the literature. Dermatol Online J. 2014;21:3.
   Google Scholar
• Lv T, Cao W, Li T. HIV-related immune activation and inflammation: current understanding and strategies. J Immunol Res. 2021;2021:7316456. doi:10.1155/2021/7316456
   PubMedGoogle Scholar
• Goldschmidt R, Chu C. HIV infection in adults: initial management. Am Fam Physician. 2021;103(7):407–416.
   PubMed Web of Science ®Google Scholar
• Duff P. Prevention of opportunistic infections in women with HIV infection. Clin Obstet Gynecol. 2019;62(4):816–822. doi:10.1097/grf.0000000000000483
   PubMed Web of Science ®Google Scholar
• Low A, Gavriilidis G, Larke N, et al. Incidence of opportunistic infections and the impact of antiretroviral therapy among HIV-infected adults in low- and middle-income countries: a systematic review and meta-analysis. Clin Infect Dis. 2016;62(12):1595–1603. doi:10.1093/cid/ciw125
   PubMed Web of Science ®Google Scholar
• Oboho IK, Paulin H, Corcoran C, et al. Modelling the impact of CD4 testing on mortality from TB and cryptococcal meningitis among patients with advanced HIV disease in nine countries. J Int AIDS Soc. 2023;26(3):e26070. doi:10.1002/jia2.26070
   PubMed Web of Science ®Google Scholar
• Sanchez-Martinez A, Perdomo-Celis F, Acevedo-Saenz L, et al. Cytotoxic CD4(+) T-cells during HIV infection: targets or weapons? J Clin Virol. 2019;119:17–23. doi:10.1016/j.jcv.2019.08.004
   PubMed Web of Science ®Google Scholar
• Glesby MJ, Hoover DR, Tan T, et al. Herpes zoster in women with and at risk for HIV: data from the Women’s Interagency HIV Study. J Acquir Immune Defic Syndr. 2004;37(5):1604–1609. doi:10.1097/00126334-200412150-00013
   PubMed Web of Science ®Google Scholar
• Gebo KA, Kalyani R, Moore RD, et al. The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era. J Acquir Immune Defic Syndr. 2005;40(2):169–174. doi:10.1097/01.qai.0000178408.62675.b0
   PubMed Web of Science ®Google Scholar
• Huang XJ, Li HY, Chen DX, et al. Clinical analysis of skin lesions in 796 Chinese HIV- positive patients. Acta Derm Venereol. 2011;91(5):552–556. doi:10.2340/00015555-1107
   PubMed Web of Science ®Google Scholar
• Josephine M, Issac E, George A, et al. Patterns of skin manifestations and their relationships with CD4 counts among HIV/AIDS patients in Cameroon. Int J Dermatol. 2006;45(3):280–284. doi:10.1111/j.1365-4632.2004.02529.x
   PubMed Web of Science ®Google Scholar
• Wiwanitkit V. Prevalence of dermatological disorders in Thai HIV-infected patients correlated with different CD4 lymphocyte count statuses: a note on 120 cases. Int J Dermatol. 2004;43(4):265–268. doi:10.1111/j.1365-4632.2004.01649.x
   PubMed Web of Science ®Google Scholar
• Li YY, Yang SH, Wang RR, et al. Effects of CD4 cell count and antiretroviral therapy on mucocutaneous manifestations among HIV/AIDS patients in Yunnan, China. Int J Dermatol. 2020;59(3):308–313. doi:10.1111/ijd.14725
   PubMed Web of Science ®Google Scholar
• Altuntaş Aydin Ö, Kumbasar Karaosmanoğlu H, Korkusuz R, et al. Mucocutaneous manifestations and the relationship to CD4 lymphocyte counts among Turkish HIV/AIDS patients in Istanbul, Turkey. Turkish J Med Sci. 2015;45(1):89–92. doi:10.3906/sag-1308-3
   PubMed Web of Science ®Google Scholar
• Morgan D, Mahe C, Malamba S, et al. Herpes zoster and HIV-1 infection in a rural Ugandan cohort. AIDS. 2001;15(2):223–229. doi:10.1097/00002030-200101260-00012
   PubMed Web of Science ®Google Scholar
• McNulty A, Li Y, Radtke U, et al. Herpes zoster and the stage and prognosis of HIV-1 infection. Genitourin Med. 1997;73(6):467–470. doi:10.1136/sti.73.6.467
   PubMedGoogle Scholar
• Sanín AM, Londoño ÁM, Gil V, et al. Mucocutaneous manifestations and their relationship with CD4 T-lymphocyte count in hospitalized patients infected with the human immunodeficiency virus (HIV) in Medellín, Colombia. Biomedica. 2022;42(2):278–289. doi:10.7705/biomedica.6117
   PubMed Web of Science ®Google Scholar
• Brahe C, Ellis R. GOT SHINGLES? TEST FOR HIV. Severe shingles as first presenting infection in HIV/AIDS patient. IDCases. 2020;19:e00725. doi:10.1016/j.idcr.2020.e00725
   PubMed Web of Science ®Google Scholar
• Lidhoo P, Unemori P, Leslie KS, et al. Disseminated herpes zoster with increased CD4 counts in 3 HIV-infected patients. J Am Acad Dermatol. 2009;61(2):345–347. doi:10.1016/j.jaad.2008.11.891
   PubMed Web of Science ®Google Scholar
• Lameiras C, Patrocínio de Jesus R, Flor-de-lima B, et al. A case of varicella-zoster virus meningomyelitis in an HIV-1-infected patient: facing the challenges related to its management and prognosis. Cureus. 2022;14(8):e27652. doi:10.7759/cureus.27652
   PubMedGoogle Scholar
• Muço E, Karruli A, Hoxha N, et al. Visceral leishmaniasis and herpes zoster as a component of syndrome of immune reconstitution inflammatory syndrome in an HIV-positive patient. Case Rep Infect Dis. 2022;2022:2784898. doi:10.1155/2022/2784898
   PubMed Web of Science ®Google Scholar
• Saxena R, Phuljhele S, Aalok L, et al. A rare case of orbital apex syndrome with herpes zoster ophthalmicus in a human immunodeficiency virus-positive patient. Indian J Ophthalmol. 2010;58(6):527–530. doi:10.4103/0301-4738.71708
   PubMed Web of Science ®Google Scholar
• Bender Ignacio RA, Ramchandani MS, Laing KJ, et al. T cell immunity to varicella-zoster virus in the setting of advanced HIV and multiple varicella-zoster virus recurrences. Viral Immunol. 2017;30(1):77–80. doi:10.1089/vim.2016.0097
   PubMed Web of Science ®Google Scholar
• Breton G, Bouldouyre MA, Gervais A, et al. Failure of valacyclovir for herpes zoster in a moderately immunocompromised HIV-infected patient. AIDS Patient Care STDS. 2004;18(5):255–257. doi:10.1089/108729104323075990
   PubMed Web of Science ®Google Scholar
• Handa S, Narang T, Wanchu A. Dermatologic immune restoration syndrome: report of five cases from a tertiary care center in north India. J Cutan Med Surg. 2008;12(3):126–132. doi:10.2310/7750.2008.07017
   PubMed Web of Science ®Google Scholar
• Ogoina D, Adekunle V, Obiako R, et al. Disseminated infections due to immune reconstitution inflammatory syndrome after highly active antiretroviral therapy--report of 3 cases from Nigeria. Pan Afr Med J. 2011;9:38. doi:10.4314/pamj.v9i1.71216
   PubMedGoogle Scholar
• Petrozza JC, Monga M, Oshiro BT, et al. Disseminated herpes zoster in a pregnant woman positive for human immunodeficiency virus. Am J Perinatol. 1993;10(6):463–464. doi:10.1055/s-2007-994633
   PubMed Web of Science ®Google Scholar
• Cohen PR, Beltrani VP, Grossman ME. Disseminated herpes zoster in patients with human immunodeficiency virus infection. Am J Med. 1988;84(6):1076–1080. doi:10.1016/0002-9343(88)90315-4
   PubMed Web of Science ®Google Scholar
• Shin BS, Na CH, Song IG, et al. A case of human immunodeficiency virus infection initially presented with disseminated herpes zoster. Ann Dermatol. 2010;22(2):199–202. doi:10.5021/ad.2010.22.2.199
   PubMed Web of Science ®Google Scholar